Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-004065-13Phase 4Completed
Phase 4, randomised, open-label trial of metformin in gestational diabetes mellitus (GDM) and impaired glucose tolerance (IGT) (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoints: Recruitment rate and Acceptability of intervention. Started Oct 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-004065-13.